questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Toxoïdes
Anatoxine staphylococcique
Anatoxine staphylococcique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections à Staphylococcus
Diagnostic microbiologique
Anticorps
Tests sérologiques
Symptômes
Infections à Staphylococcus
Staphylococcus
Identification des espèces
Anatoxines
Réponse immunitaire
Symptômes
5
Intoxication alimentaire
Symptômes
Infections cutanées
Furoncles
Variabilité des symptômes
Staphylococcus
Réactions allergiques
Anatoxines
Prévention
5
Prévention des infections
Hygiène
Infections nosocomiales
Contrôle des infections
Vaccination
Personnes à risque
Transmission des infections
Hygiène personnelle
Traitements
5
Antibiotiques
Infections à Staphylococcus
Toxoïdes
Prévention des infections
Réactions allergiques
Antihistaminiques
Soins des plaies
Infections cutanées
Antibiotiques
Infections à Staphylococcus
Complications
5
Effets secondaires
Réactions allergiques
Septicémie
Défaillance organique
Gestion des complications
Antibiotiques
Infections chroniques
Traitement prolongé
Facteurs de risque
5
Facteurs de risque
Système immunitaire
Diabète
Infections à Staphylococcus
Athlètes
Infections cutanées
Hygiène
Infections communautaires
Personnes âgées
Système immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Anatoxine staphylococcique : Questions médicales les plus fréquentes",
"headline": "Anatoxine staphylococcique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Anatoxine staphylococcique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Anatoxine staphylococcique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Toxoïdes",
"url": "https://questionsmedicales.fr/mesh/D014121",
"about": {
"@type": "MedicalCondition",
"name": "Toxoïdes",
"code": {
"@type": "MedicalCode",
"code": "D014121",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.691"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Anatoxine staphylococcique",
"alternateName": "Staphylococcal Toxoid",
"code": {
"@type": "MedicalCode",
"code": "D013208",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fiona P Havers",
"url": "https://questionsmedicales.fr/author/Fiona%20P%20Havers",
"affiliation": {
"@type": "Organization",
"name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fhavers@cdc.gov."
}
},
{
"@type": "Person",
"name": "Susan Hariri",
"url": "https://questionsmedicales.fr/author/Susan%20Hariri",
"affiliation": {
"@type": "Organization",
"name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States."
}
},
{
"@type": "Person",
"name": "Nasamon Wanlapakorn",
"url": "https://questionsmedicales.fr/author/Nasamon%20Wanlapakorn",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
},
{
"@type": "Person",
"name": "Donchida Srimuan",
"url": "https://questionsmedicales.fr/author/Donchida%20Srimuan",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
},
{
"@type": "Person",
"name": "Thaksaporn Thatsanathorn",
"url": "https://questionsmedicales.fr/author/Thaksaporn%20Thatsanathorn",
"affiliation": {
"@type": "Organization",
"name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36068430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40264-022-01216-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ferric Carboxymaltose in Heart Failure with Iron Deficiency.",
"datePublished": "2023-08-26",
"url": "https://questionsmedicales.fr/article/37632463",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1056/NEJMoa2304968"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ferric Pyrophosphate Forms Soluble Iron Coordination Complexes with Zinc Compounds and Solubilizing Agents in Extruded Rice and Predicts Increased Iron Solubility and Bioavailability in Young Women.",
"datePublished": "2022-12-24",
"url": "https://questionsmedicales.fr/article/36931746",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tjnut.2022.12.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35947351",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12325-022-02242-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35790696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12185-022-03401-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Toxoïdes",
"item": "https://questionsmedicales.fr/mesh/D014121"
},
{
"@type": "ListItem",
"position": 6,
"name": "Anatoxine staphylococcique",
"item": "https://questionsmedicales.fr/mesh/D013208"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Anatoxine staphylococcique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Anatoxine staphylococcique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Anatoxine staphylococcique",
"description": "Comment diagnostiquer une infection staphylococcique ?\nQuels tests sont utilisés pour détecter l'anatoxine ?\nQuels symptômes indiquent une infection staphylococcique ?\nComment différencier les types de staphylocoques ?\nQuel rôle joue l'anatoxine dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Ferric+Compounds#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Anatoxine staphylococcique",
"description": "Quels sont les symptômes d'une intoxication par anatoxine ?\nComment se manifestent les infections cutanées staphylococciques ?\nQuels signes indiquent une infection systémique ?\nLes symptômes varient-ils selon le type de staphylocoque ?\nQuels symptômes sont associés à l'anatoxine staphylococcique ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Ferric+Compounds#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Anatoxine staphylococcique",
"description": "Comment prévenir les infections staphylococciques ?\nL'anatoxine staphylococcique est-elle vaccinante ?\nQuelles mesures de prévention en milieu hospitalier ?\nLes personnes à risque doivent-elles se faire vacciner ?\nComment éviter la transmission en milieu communautaire ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Ferric+Compounds#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Anatoxine staphylococcique",
"description": "Quel traitement est recommandé pour une infection staphylococcique ?\nL'anatoxine staphylococcique est-elle un traitement ?\nComment traiter une réaction à l'anatoxine ?\nQuels soins sont nécessaires pour les infections cutanées ?\nQuand utiliser des antibiotiques pour les infections staphylococciques ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Ferric+Compounds#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Anatoxine staphylococcique",
"description": "Quelles complications peuvent survenir avec une infection staphylococcique ?\nL'anatoxine peut-elle provoquer des effets secondaires ?\nQuels sont les risques d'une septicémie staphylococcique ?\nComment gérer les complications d'une infection ?\nLes infections staphylococciques peuvent-elles être chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Ferric+Compounds#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Anatoxine staphylococcique",
"description": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?\nLes personnes diabétiques sont-elles plus à risque ?\nLes athlètes sont-ils à risque d'infections cutanées ?\nComment l'hygiène influence-t-elle le risque d'infection ?\nLes personnes âgées sont-elles plus vulnérables ?",
"url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Ferric+Compounds#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection staphylococcique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter l'anatoxine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques peuvent être utilisés pour détecter des anticorps contre l'anatoxine."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection staphylococcique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent rougeurs, gonflements, douleurs et parfois fièvre."
}
},
{
"@type": "Question",
"name": "Comment différencier les types de staphylocoques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses génétiques aident à identifier les espèces."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'anatoxine dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anatoxine est utilisée pour évaluer la réponse immunitaire aux infections staphylococciques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication par anatoxine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des nausées, vomissements et diarrhées."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les infections cutanées staphylococciques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se manifestent par des furoncles, des abcès et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection systémique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, frissons, et signes de septicémie peuvent indiquer une infection systémique."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de staphylocoque ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la souche et le site d'infection."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à l'anatoxine staphylococcique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des réactions allergiques et des douleurs au site d'injection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections staphylococciques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et désinfecter les blessures aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "L'anatoxine staphylococcique est-elle vaccinante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour immuniser contre certaines infections staphylococciques."
}
},
{
"@type": "Question",
"name": "Quelles mesures de prévention en milieu hospitalier ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protocoles stricts d'hygiène et de désinfection sont essentiels en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles se faire vacciner ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes à risque d'infections staphylococciques devraient envisager la vaccination."
}
},
{
"@type": "Question",
"name": "Comment éviter la transmission en milieu communautaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le partage d'objets personnels et maintenir une bonne hygiène personnelle."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour une infection staphylococcique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont souvent prescrits, selon la sensibilité de la souche."
}
},
{
"@type": "Question",
"name": "L'anatoxine staphylococcique est-elle un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, c'est un toxoïde utilisé pour la prévention, pas pour le traitement."
}
},
{
"@type": "Question",
"name": "Comment traiter une réaction à l'anatoxine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent nécessiter des antihistaminiques ou des corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires pour les infections cutanées ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un drainage des abcès et des soins locaux sont souvent nécessaires."
}
},
{
"@type": "Question",
"name": "Quand utiliser des antibiotiques pour les infections staphylococciques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont utilisés lorsque l'infection est confirmée et nécessite un traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une infection staphylococcique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections profondes, des septicémies et des chocs toxiques."
}
},
{
"@type": "Question",
"name": "L'anatoxine peut-elle provoquer des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des douleurs au site d'injection et des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une septicémie staphylococcique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La septicémie peut entraîner des défaillances organiques et un risque accru de mortalité."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une infection ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prise en charge rapide avec des antibiotiques et des soins intensifs est cruciale."
}
},
{
"@type": "Question",
"name": "Les infections staphylococciques peuvent-elles être chroniques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent devenir chroniques et nécessiter un traitement prolongé."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un système immunitaire affaibli, des interventions chirurgicales et des blessures."
}
},
{
"@type": "Question",
"name": "Les personnes diabétiques sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète augmente le risque d'infections staphylococciques en raison de la circulation sanguine altérée."
}
},
{
"@type": "Question",
"name": "Les athlètes sont-ils à risque d'infections cutanées ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les athlètes peuvent être à risque en raison de blessures et de contacts fréquents."
}
},
{
"@type": "Question",
"name": "Comment l'hygiène influence-t-elle le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise hygiène augmente le risque d'infections staphylococciques, surtout dans les milieux communautaires."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fhavers@cdc.gov.
Publications dans "Anatoxine staphylococcique" :
3 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Science, University of Tennessee, Knoxville, TN, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Science, University of Tennessee, Knoxville, TN, United States.
East Tennessee AgResearch and Education Center-Little River Animal and Environmental Unit, University of Tennessee, Walland, TN, United States.
Publications dans "Anatoxine staphylococcique" :
2 publications dans cette catégorie
Affiliations :
NYU School of Medicine, Skirball Institute of Biomolecular Medicine and Departments of Medicine and Microbiology, New York, NY 10016.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 100050, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, San Jose 95134, USA.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China. Electronic address: xluo@ipe.ac.cn.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 100050, China. Electronic address: maxiao421@sina.cn.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
1 publication dans cette catégorie
Affiliations :
ThermoFisher Scientific Corporation, Beijing 100080, China.
Publications dans "Anatoxine staphylococcique" :
The intravenous iron formulations ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) offer the possibility of administering a large amount of iron in one infusion. This results in faster corre...
Ferric carboxymaltose therapy reduces symptoms and improves quality of life in patients who have heart failure with a reduced ejection fraction and iron deficiency. Additional evidence about the effec...
In this double-blind, randomized trial, we assigned ambulatory patients with heart failure, a left ventricular ejection fraction of 40% or less, and iron deficiency, in a 1:1 ratio, to receive intrave...
We enrolled 3065 patients, of whom 1532 were randomly assigned to the ferric carboxymaltose group and 1533 to the placebo group. Death by month 12 occurred in 131 patients (8.6%) in the ferric carboxy...
Among ambulatory patients who had heart failure with a reduced ejection fraction and iron deficiency, there was no apparent difference between ferric carboxymaltose and placebo with respect to the hie...
Co-extrusion of ferric pyrophosphate (FePP) with solubilizers, citric acid/trisodium citrate (CA/TSC), or ethylenediaminetetraacetic acid (EDTA) sharply increases iron absorption. Whether this can pro...
Our objectives were to 1) investigate the ligand coordination of iron, zinc, and solubilizers in extruded rice and test associations with iron solubility and absorption, 2) assess whether co-extrusion...
We produced labeled...
The addition of zinc and solubilizers created new iron coordination complexes of Fe(III) species with a weak ligand field at a high-spin state that correlated with solubility (r...
Rice extrusion of FePP with solubilizers resulted in bioavailable iron coordination complexes. In the case of FePP + CA/TSC, PA exerted similar inhibition of FIA as with FeSO...
Intravenous (IV) iron is the preferred treatment for patients with iron deficiency anemia (IDA) who require rapid replenishment of iron stores or in whom oral iron is not tolerated or effective. Data ...
RCTs reporting the incidence of blindly adjudicated cardiovascular events in IDA patients treated with IV iron were identified by systematic literature review (SLR). Pairwise random effects meta-analy...
The SLR retrieved 694 unique articles, of which four were RCTs reporting the incidence of the composite cardiovascular endpoint; two studies comparing FCM (N = 1529) with IS (N = 1505), and two studie...
Pooling data from four large-scale RCTs suggested that FDI was associated with significantly lower incidence of cardiovascular adverse events compared to both FCM and IS....
A multicenter, randomized, open-label, phase III study was conducted to compare the efficacy and safety of intravenous ferric derisomaltose (FDI) versus saccharated ferric oxide (SFO) in Japanese pati...
Bioremediation provides an environmentally sound solution for hydrocarbon removal. Although bioremediation under anoxic conditions is slow, it can be coupled with methanogenesis and is suitable for en...
The randomized IronIC trial evaluated the effect of intravenous ferric derisomaltose on physical capacity in iron-deficient, maintenance heart transplant (HTx) recipients. Iron deficiency was defined ...
We assessed key governors of iron homeostasis, such as hepcidin, soluble transferrin receptor (sTfR), and interleukin-6 (IL-6). We also measured growth factors and inflammatory markers with relevance ...
Hepcidin did not differ between HTx recipients and controls, even though markers of inflammation were modestly elevated. However, HTx recipients with ferritin <30 μg/L or sTfR above the reference rang...
HTx recipients with iron deficiency as defined in heart failure do not have elevated hepcidin levels, although inflammatory markers are modestly increased. The high ferritin cut-offs used in heart fai...
In this study, a fast, reproducible and simple-to-apply a new potentiometric determination method was developed for the evaluation of iron (III) reducing power (FRAP), one of the antioxidant capacity ...
The heterogeneous Fenton-like reaction (HeFR) has always been a research focus for environmental applications. However, it has long been difficult to reach a consensus on the reaction mechanism becaus...
Cardiovascular diseases are a leading cause of mortality and morbidity worldwide. Aberrant thrombosis is a common feature of systemic conditions like diabetes and obesity, and chronic inflammatory dis...